A new preprint describes a single-step molecular diagnostic test for the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection caused by the Omicron variant that is behind ...
Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the launch of its Codex® HiTemp Reverse Transcriptase for use in one-step ...
As the need for more sensitive and precise molecular quantification grows across translational research, diagnostics, and therapeutic development, conventional PCR workflows can fall short. Detecting ...
Countable PCR delivers single-molecule precision for Europe's most demanding quantification challenges — from cell and gene therapy manufacturing to biomarker validation, diagnostics, commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results